Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Sequent Partners on acquisition of Estate Group
Mandate

Vinge advises Sequent Partners on acquisition of Estate Group

May 31, 2012

Vinge is advising Sequent Partners in connection with the acquisition of Estate Group in Sweden AB. Sequent is an active, long term and transparent investor in owner driven companies in the Nordic region. Estate Group is a Swedish facilities management services provider, delivering everything from small-scale service solutions to complete outsourcing. Estate's gross turnover in 2011 amounted to MSEK 150.

The Vinge team advising Sequent includes partner Daniel Rosvall and associates Peter Sundgren and Mattias Kelmeling (M&A), Robing Dangoor (banking & finance), and Åsa Gotthardsson and Karin Isacson (employment & benefits).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026